MTHFR C677T, FII G20210A, FV Leiden G1691A, NOS3 intron 4 VNTR, and APOE ε4 gene polymorphisms are not associated with spontaneous cervical artery dissection

International Journal of Stroke

Volumn 5, Issue 2, 2010, Pages 80-85

  Jara Prado, A ^a   Alonso, M E ^a   Martinez Ruano L ^a   Guerrero Camacho, J ^a   Leyva, A ^b   Lopez M ^c   Gutierrez Castrellon, P ^d   Arauz, A ^a,b  

^a National Institute of Neurogenetics and Neurosurgery   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^d INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Cervical artery dissection; Genetics; Prothrombotic gene mutations

Indexed keywords

ADENINE; APOLIPOPROTEIN E4; BLOOD CLOTTING FACTOR 5 LEIDEN; CYTOSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); THROMBOCYTE FACTOR 2; THYMINE;

ADULT; AGE; ALLELE; ANAMNESIS; ARTERY DISSECTION; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CAROTID ARTERY INJURY; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; INTRON; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; APOLIPOPROTEINS E; DEMOGRAPHY; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT FAILURE; TREATMENT OUTCOME; VERTEBRAL ARTERY DISSECTION;

EID: 77951251198     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00412.x     Document Type: Article

References (33)

1. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001, 344:898-906.
2. Barinagarrementeria F, Figueroa T, Huebe J, Cantú C. Cerebral infarction in people under 40 years: etiologic analysis of 300 cases prospectively evaluated. Cerebrovasc Dis 1996, 6:75-9.
3. Rubinstein SM, Peerdeman SM, van Tulder MW, Riphagen I, Haldeman S. A systematic review of the risk factor for cervical artery dissection. Stroke 2005, 36:1575-80.
4. Brandt T, Grond-Ginsbach C. Spontaneous cervical artery dissection. From risk factors toward pathogenesis. Stroke 2002, 33:657-8.
5. Guillon B, Bousser MG. Epidemiology and pathophysiology of spontaneous cervical artery dissection. J Neuroradiol 2002, 29:241-9.
6. Grond-Ginsbach C, Debette S, Pezzini A. Genetic approaches in the study of risk factors for cervical artery dissection. Front Neurol Neurosci 2005, 20:30-43.
7. Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study. Arch Intern Med 2000, 160:961-4.
8. Gallai V, Caso V, Paciaroni M. Mild hyperhomocyst(e)inemia: a possible risk factor for cervical artery dissection. Stroke 2001, 32:714-8.
9. Konrad C, Müller GA, Langer C. Plasma homocysteine, MTHFR C677T, CBS 844ins68pb, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol 2004, 251:1242-8.
10. Pezzini A, Del Zotto E, Archetti S. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 2002, 33:664-9.
11. Kloss M, Wiest T, Hyrenbach S. MTHFR 677TT genotype increases the risk for cervical artery dissections. J Neurol Neurosurg Psychiatry 2006, 77:951-2.
12. Arauz A, Hoyos L, Cantú C. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection. Cerebrovasc Dis 2007, 24:210-4.
13. McColgan P, Sharma P. The genetics of carotid dissection: meta-analysis of a MTHFR/C677T common molecular variant. Cerebrovascular Dis 2008, 25:561-5.
14. Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Inter Med 2003, 138:128-34.
15. Lüdemann P, Nabavi DG, Junker R. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke 1998, 29:2507-10.
16. Cardon C, Diemont F, Julia P, Chemia E, Fabiani JN. Bilateral carotid dissection and factor V mutation: a second case. Ann Vasc Surg 2000, 5:503-6.
17. Poort SR, Rosendal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothombin levels and an increase in venous thrombosis. Blood 1996, 88:3698-703.
18. Reuner KH, Ruf A, Grau A. Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis. Stroke 1998, 29:1765-9.
19. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994, 198:1027-33.
20. Wang Y, Kikuchi S, Suzuki H, Nagase S, Koyama A. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases. Nephrol Dial Transplant 1999, 14:2898-902.
21. Wang XL, Sim AS, Badenhop RF, Mccredie RM, Wilcken DEL. A smoking dependent risk of coronary artery disease associated with a polymorphism of the endothelial constitutive nitric oxide synthase gene. Nature Med 1996, 2:41-5.
22. Hassan A, Gormley K, O'Sullivan M. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 2004, 35:654-9.
23. Eichner JE, Dunn ST, Perveen G, Thompsom DM, Stewart KE, Stroehla BC. Apolipoproteína E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002, 155:487-95.
24. Sing CF, Davignon J. Role of apolipoprotein E genetic polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985, 37:268-85.
25. Davignon J, Gregg RE, Sing SF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988, 8:1-21.
26. Sudlow C, Martínez González NA, Kim J, Clark C. Does apolipoproteína E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17965 controls. Stroke 2006, 37:364-70.
27. Orlandi G, Fanucchi S, Mancuso M. Dissection and atherosclerosis of carotid arteries in the young: role of the apolipoprotein E polymorphism. Eur J Neurol 2002, 1:19-21.
28. Frosst P, Blom HJ, Milos R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-3.
29. Ripoll L, Paulin D, Thomas S, Drouet O. (1997) Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene. Thromb Haemost 1997, 78:960-1.
30. Hixon JE, Vernier DT. Restriction isotoping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990, 31:545-7.
31. Nowak-Göttl U, Sträter, Heinecke A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, Prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999, 94:3678-82.
32. Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997, 78:1430-3.
33. Khurana VG, Sohni YR, Mangrum WI. Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurismal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metabol 2004, 24:291-7.